Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by Annayya on Mar 22, 2021 11:27am

Halted

What's the big news :) Waited so many years for various things. Hopefully this is huge.
Comment by Annayya on Mar 22, 2021 11:33am
Is it just a financing news of $8.75 million, or were they testing the halting system to see if it works for the future bigger news.
Comment by G1945V on Mar 22, 2021 11:47am
Also: The company also said chief executive Elliot Goldstein, 70, will retire at ye ar end. A search for his successor is under way. G1945V
Comment by M101 on Mar 22, 2021 12:00pm
 Oh no, it not just the financing it's the QUALITY investors elliot personally interviewed (unlike you and me), with their bodacious BOSTON bona fides.   I mean the header is bizarre, but yes Elliot we get it, you finally found some investors who won't be churning 10s of millions of shares. Congratulations and don't let the door hit you on the way out. 
Comment by Mole101 on Mar 22, 2021 12:14pm
Expanding our management team, capitalizing on the talent pool in Boston, to support a growing and ambitious scope of activity.
Comment by M101 on Mar 22, 2021 2:14pm
Got to expand managment, absolutely.  Maybe get rid of the lab to help pay for it, that guy Cashman wtf does he do anyway.   Golden parachute for Elliot too, $10,000,000 would buy a nice thank-you card. 
Comment by Mole101 on Mar 22, 2021 2:51pm
i don't think PMN310 is going to stay in the back burner for long. We can be as sarcastic as We like but no where yo go but up from here . Change and the fact someone is willing to put $$ on pmn it's good news   
Comment by M101 on Mar 22, 2021 3:25pm
Sarcasm aside, that they would even mention expanding management is a huge red flag for me.  Getting a clinical result is the only thing that matters right now so putting that comment in that news release can only be laying the groundwork for not getting job #1 done with the money finally at hand. Elliot's job is done. He could and should step aside today. 
Comment by retiredcop on Mar 22, 2021 3:59pm
Everyone has missed the biggest benefit of this announcement .... as another long time shareholder pointed out to me ' We now have the parent companies of the Boston Red Sox and the New England Patriots as shareholders of PMN
Comment by M101 on Mar 22, 2021 4:32pm
Sure RC, it's not nothing and the stock may stay hold a cent or two premium over the debenture price because of it. But management was the problem so it it still is. Clinical testing is listed as the top priority but it came not with a firm committment but rather the fudge as convenient statement "accelerate progress toward a number of top priorities, including"    I ...more  
Comment by farmerjane on Mar 22, 2021 4:42pm
Why did they bring the NASDAQ up again? Doesn't the stock have to a few dollars not a penny stock to get listed?
Comment by retiredcop on Mar 22, 2021 7:12pm
Pretty.simple..roll.back.shares 10 or 15 to 1..
Comment by retiredcop on Mar 22, 2021 7:19pm
Comment by farmerjane on Mar 23, 2021 12:18am
And wait for another 4 months with no news, then these billionares can come in take another PP, or take it private at that point.  I'm sure they can grease Elliot and Eugene?
Comment by M101 on Mar 23, 2021 10:30am
Elliot has done his best to maintain control with an ever shrinking fraction of the diluted total, so that risk while real is not impending.  Interested to hear more on this topic.  
Comment by Annayya on Mar 23, 2021 1:13pm
They wouldn't invest almost $9 million CAD if they thought there was no significant news in the near future. Also, since they are again looking to get PMN on NASDAQ and made that a priority based on the things listed in the news release yesterday, I don't think they are considering taking this company private any time soon.
Comment by retiredcop on Mar 22, 2021 7:21pm
Or.maybe they expect.the shares price to go.over 1$ in the near future..
Comment by Annayya on Mar 22, 2021 6:38pm
Looking forward to the bright future of PMN with continued support from our new billionaire investors/companies (Robert Kraft and John W. Henry). With their financial support, management can truly advance the PMN310 into clinical testing. They don't need to look for partners desperately and waste too much time going forward, and can focus more on achieving the company objectives. If the ...more  
Comment by JoeyBoston on Mar 22, 2021 4:16pm
Holy Smokes. This is HUGE news. We got a couple of Billionnaires (yes, not millionnaires but billionaires) funding our company! Goodbye any funding worries. Removing that risk alone should make this a $50-$100M cap size. Should be a quick path to Phase 1, 2, etc. which will drive the valuation higher.  Bought some more today after I saw the press release. Good luck everyone.
Comment by BottomBroker on Mar 22, 2021 2:59pm
Zactly. Expanding revenue first would be nice. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities